TABLE 2

Antibiotics and growth inhibitors exhibiting a significant different between FL and GC samples in PM assaysa

PlateWellGrowth InhibitorAUCP value
FLGC
11CB12Lomefloxacin3,222 ± 7764,509 ± 1350.0470
11CE08Enoxacin2,508 ± 62744 ± 580.0025
11CE11Nalidixic Acid2,496 ± 2003,437 ± 1050.0019
12BB06Penimepicycline3,738 ± 2694,400 ± 1600.0216
13BC026-Mercaptopurine3,722 ± 8941,835 ± 110.0216
13BD09Rolitetracycline4,556 ± 534,998 ± 1670.0120
13BF03Cesium chloride3,219 ± 683,642 ± 1120.0051
13BF04Cesium chloride2,467 ± 913,139 ± 1000.0010
13BG07Manganese(II) chloride5,391 ± 1205,713 ± 1330.0352
13BG10Trifluoperazine3,659 ± 7492,018 ± 6280.0437
  • a Data are presented as the means ± standard deviations of AUC values (n = 3). Differences with P ≤ 0.05 (Student's t test) were considered significant.